as 06-30-2025 3:31pm EST
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Founded: | 1996 | Country: | United States |
Employees: | N/A | City: | DURHAM |
Market Cap: | 469.0M | IPO Year: | N/A |
Target Price: | $17.10 | AVG Volume (30 days): | 3.0M |
Analyst Decision: | Hold | Number of Analysts: | 11 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -8.81 | EPS Growth: | N/A |
52 Week Low/High: | $3.97 - $28.41 | Next Earning Date: | 08-11-2025 |
Revenue: | $2,685,600,000 | Revenue Growth: | -4.45% |
Revenue Growth (this year): | -4.84% | Revenue Growth (next year): | 1.36% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Mcconnell Jill G. | FTRE | Chief Financial Officer | Jun 2 '25 | Sell | $4.17 | 3,130 | $13,052.10 | 48,344 | |
Morais Mark A. | FTRE | Chief Operating Officer | Jun 2 '25 | Sell | $4.17 | 3,130 | $13,052.10 | 46,549 | |
Hanson James S. | FTRE | General Counsel | Jun 2 '25 | Sell | $4.17 | 2,191 | $9,136.47 | 14,981 |
FTRE Breaking Stock News: Dive into FTRE Ticker-Specific Updates for Smart Investing
Zacks
5 days ago
Argus Research
6 days ago
Simply Wall St.
7 days ago
GlobeNewswire
7 days ago
Zacks
11 days ago
TipRanks
18 days ago
GlobeNewswire
19 days ago
GlobeNewswire
19 days ago
The information presented on this page, "FTRE Fortrea Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.